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ABSTRACT
Objective: To explore how patients who are wait-listed
for or who have received a kidney transplant
understand the current UK kidney allocation system,
and their views on ways to allocate kidneys in the
future.
Design: Qualitative study using semistructured
interviews and thematic analysis based on a pragmatic
approach.
Participants: 10 deceased-donor kidney transplant
recipients, 10 live-donor kidney transplant recipients,
12 participants currently wait-listed for a kidney
transplant and 4 participants whose kidney transplant
failed.
Setting: Semistructured telephone interviews
conducted with participants in their own homes across
the UK.
Results: Three main themes were identified:
uncertainty of knowledge of the allocation scheme;
evaluation of the system and participant suggestions
for future allocation schemes. Most participants
identified human leucocyte anitgen matching as a
factor in determining kidney allocation, but were often
uncertain of the accuracy of their knowledge. In the
absence of information that would allow a full
assessment, the majority of participants consider that
the current system is effective. A minority of
participants were concerned about the perceived lack
of transparency of the general decision-making
processes within the scheme. Most participants felt
that people who are younger and those better matched
to the donor kidney should be prioritised for kidney
allocation, but in contrast to the current scheme, less
priority was considered appropriate for longer waiting
patients. Some non-medical themes were also
discussed, such as whether parents of dependent
children should be prioritised for allocation, and
whether patients with substance abuse problems be
deprioritised.
Conclusions: Our participants held differing views
about the most important factors for kidney allocation,
some of which were in contrast to the current scheme.
Patient participation in reviewing future allocation
policies will provide insight as to what is considered
acceptable to patients and inform healthcare staff of
the kinds of information patients would find most
useful.
INTRODUCTION
Transplantation is widely viewed as the best
treatment for most people with advanced
chronic kidney disease (CKD).1 Although
transplant rates are increasing, there con-
tinues to be a mismatch between supply and
demand.2 3 National kidney allocation pol-
icies aim to balance the competing goals of
optimising outcomes and providing equity of
access to donated organs, in a way that is
acceptable to patients and healthcare profes-
sionals. In the current UK allocation scheme
Strengths and limitations of this study
▪ Qualitative methods such as thematic analysis
are well suited to understanding the beliefs
underlying individual attitudes and opinions of
the current kidney allocation system.
▪ The study interviewed a wide selection of partici-
pants, including those currently waiting for a
transplant, participants who received a deceased
donor or living-donor transplant and those
whose transplant failed.
▪ The interviews were conducted with participants
recruited to Access to Transplantation and
Transplant Outcomes (ATTOM) so the results
cannot be generalised necessarily to all renal
patients or other organ allocation schemes.
▪ Only English-speaking participants were recruited
so the results may not reflect fully the views of
people of ethnic minority origin. Those patients
deemed unsuitable for transplant listing were
also not recruited.
Gibbons A, et al. BMJ Open 2017;7:e013896. doi:10.1136/bmjopen-2016-013896 1
Open Access Research
for kidneys from deceased heart-beating donors,4 5 per-
fectly matched kidneys are prioritised for children
(<18 years), patients with antibodies to numerous
human leucocyte antigens (HLA) and patients homozy-
gous for HLA-DR. Within these groups, longer waiting
patients get priority. Imperfectly matched kidneys are
offered to blood-group and HLA-compatible recipients
using a points-based system taking into account waiting
time and recipient age and HLA-mismatch, aiming to
give younger patients better-matched kidneys. Other
factors for which points are given include HLA-DR and
HLA-B homozygosity, age difference between donor and
recipient, blood-group match and geographical location
of recipient and donor to minimise extracorporeal
kidney storage time. When a donor is identified, kidneys
are offered sequentially to wait-listed patients starting
with the highest-ranked patient, then the next highest,
until accepted. This scheme was introduced in 2006;4 5
details are available online (http://www.odt.nhs.uk/pdf/
kidney_allocation_policy.pdf). Since then, there have
been significant changes in donor and recipient demo-
graphics, and other factors have emerged as predictors
of post-transplant outcomes. In line with the objectives
of the scheme,4 recent discussions suggest a shift in
focus towards ‘transplant benefit’ and matching more
carefully the donor and recipient. For this reason, the
Kidney Advisory Group of National Health Service
Blood and Transplant are reviewing the UK kidney allo-
cation system.
Involving stakeholders in developing kidney allocation
schemes helps ensure acceptability.6 Patients’ perspec-
tives and their preferences for factors determining alloca-
tion are important for assessing the acceptability of a
system and managing patients’ expectations of outcomes.
Accounting for the outcomes most important to patients
may improve patient satisfaction and their ability to make
informed decisions regarding listing, but few studies have
been conducted on the views of renal patients about
kidney allocation schemes. Such studies have indicated
broad agreement between factors considered important
to patients and those used, such as HLA matching.7 8
Most UK studies have used discrete choice experiments
or questionnaire surveys,8–10 thus not allowing for further
explanation of the reasoning and beliefs behind peoples’
preferences or the opportunity to assess how patients
interpret questions. Qualitative research, in contrast, pro-
vides a deeper understanding of the beliefs underlying
individual attitudes and opinions and is capable of identi-
fying unanticipated beliefs or preferences. The objectives
of this study were to identify what patients know and
think of the current UK kidney allocation system, and
what factors they believe should influence allocation.
METHOD
Study context
This qualitative study was conducted as part of the
Access to Transplantation and Transplant Outcomes
(ATTOM) programme.11 ATTOM aimed to examine the
reasons for disparities in transplant availability12 13 and
learn how to optimise UK transplant outcomes.
Research nurses from all 72 UK renal units recruited
participants from November 2011 to March 2013. The
current study was conducted within a work-stream exam-
ining detailed patient-reported outcome measures in
651 patients fluent in English receiving differing treat-
ments for stage 5 CKD, who completed questionnaires
on quality of life and treatment satisfaction. Methods
have been reported in detail elsewhere.11 The main aim
of the interviews was to explore participant’s question-
naire responses related to their quality of life and treat-
ment satisfaction, and additionally explore participants’
thoughts about how kidneys are allocated, which is the
focus of this paper. Thematic analysis based on a prag-
matic approach was used. This is a flexible approach not
limited to any one epistemology that acknowledges there
are differing ways of making sense of the world. Analyses
were conducted in line with established guidelines.14
Participants
To ensure inclusion of participants who reported differ-
ing levels of negative impact of their renal condition on
their quality of life (QoL), participants were selected
based on their Renal Dependent Quality of Life
(RDQoL) questionnaire15 scores, completed 12 months
following recruitment to ATTOM. The RDQoL is a
21-item disease-specific measure of the impact of CKD
on QoL. The impact of CKD on various life domains,
and the importance of these domains for QoL, are rated
by participants. Impact is multiplied by importance to
give a weighted-impact score for each domain. Average
weighted-impact (AWI) scores are calculated by dividing
the summed weighted-impact scores of each applicable
domain by the number of applicable domains, to give a
score between −9 (most negative impact) and +3 (most
positive impact). Means and SDs were calculated from a
subsample of 256 participants. Selecting participants
with scores either above or below one SD of the mean
allowed for consistent criteria to be used across treat-
ment groups, and selected participants from a wide
range of RDQoL AWI scores. Participants were not strati-
fied by demographic variables, but the groups were rep-
resentative of their cohorts for age, sex and ethnicity,
although the living-donor kidney (LD) recipients inter-
viewed were older than the average LD recipient.
Sixty participants were selected to take part (see online
supplementary appendix 1); 40 agreed, and 38 were
interviewed. Of the 20 who did not participate, 6
declined, 2 were too ill and 12 could not be contacted.
Two agreed to participate but could not subsequently be
contacted. Two interviews were excluded from analyses (1
wait-listed patient was removed from the list and 1 trans-
plant recipient reported transplant failure at interview).
Interview schedule
An interview schedule was developed (box 1), guided by
the published literature.16 Participants were asked about
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their knowledge of the kidney allocation system, and
how they would like to see kidneys allocated in future.
The interview also included a list of 13 factors that are
or could potentially be used to determine allocation
(table 1). The list included factors that are used in the
UK scheme and those considered important by patients
in previous research.7–10 16 Current determinants of allo-
cation were comprehensibly phrased; for example, cold
ischaemia time was referred to as the ‘travelling distance
between donor kidney and recipient’. Other factors
were related to one another, such as likelihood of dying
without a transplant and gain in life expectancy, but
were assessed separately, in line with previous research.7
Participants were asked to rate the importance of these
factors in deciding priority for who should be allocated
a kidney from 0 (not at all important) to 10 (most
important). All factors were rated by participants at the
end of the interviews, to avoid influencing participants’
opinions about the system. Participants were encouraged
to elaborate on their answers and to think out loud
when making their ratings.
Data collection
Semistructured telephone interviews were conducted
between December 2013 and August 2014. All partici-
pants had been contacted previously by authors (AG or
JB) when arranging completion of questionnaires.
Postdoctoral research fellow (AG) conducted the inter-
views. She has qualitative research experience and
formal training including the use of NVivo software
(QSR International, US) for qualitative analysis.
Participants were informed that the interview would
explore their questionnaire responses related to their
QoL and treatment satisfaction, to broaden the research
team’s understanding of participant experiences. The
interview would also explore participants’ thoughts
about how kidneys are allocated (box 1). Participants
agreeing to take part were phoned at an agreed time for
interview.
Data analysis
Interviews were audio-recorded and transcribed. Field
notes were made by AG after every interview. Interviews
averaged 52 min in length (range =28–91 min). Field
notes were reviewed and transcripts read three times for
familiarisation prior to analysis. Independent initial
coding by AG of 5 interviews established major themes
derived from the data which enabled development of a
coding framework (AG, CB, MC). This showed signifi-
cant levels of agreement on independent coding of the
Box 1 Questions regarding kidney allocation from the
wider interview schedule
The broad questions were asked of all participants. The second
set of questions include examples of questions used selectively to
obtain further information or explanation from participants.
Broad questions
▸ Can you please tell me what you know of the current system
that is used for allocating kidneys to people on the waiting
list?
▸ Where did you learn about the allocation system?
▸ If you could decide how the allocation system works, how
would you like to see the kidneys being allocated?
▸ Who do you think should decide who receives a kidney?
Examples of prompts and probing questions
▸ What factors determine who gets a kidney?
▸ Can you tell me what you know of how tissue type and blood
group influence kidney allocation? Can you tell me how the
system tries to reduce the risk of rejection in other ways?
▸ Can you tell me what you know of how waiting time affects
kidney allocation?
▸ What sort of person do you think is most likely to get a
kidney? Why do you think that they have this advantage? Is
this fair?
▸ Do you think that there are other people who should have an
advantage? Who? Why?
▸ What sort of person do you think is least likely to get a
kidney? Why do you think so? Is this fair?
▸ Do you think it is important that everyone has an equal
chance of getting a kidney? Why?
▸ Do you think that sometimes people shouldn’t have an equal
chance? Who? Why?
▸ Where did you learn about the allocation system; healthcare
staff? Other patients? The internet?
▸ Was the information you were given consistent with other
information you received?
▸ What factors should be taken into account when deciding who
receives a kidney?
▸ What factors do you think should be given priority? Can you
explain why?
Table 1 Participants’ ratings of how important they
believe each factor to be in reaching a decision about who
receives a kidney transplant as evidenced by mean
importance scores
Ranking Factor Mean SD Range
1 HLA/tissue matching 8.66 1.76 1–10
2 Likelihood of dying
without a transplant
8.30 1.72 5–10
3 Age <18 years of
potential recipient
8.28 2.09 3–10
4 Blood-group match 8.09 2.33 1–10
5 Gain in quality of health 7.58 2.25 0–10
6 Travelling distance
between donor kidney
and recipient
7.51 2.76 0–10
7 Age 18–60 years 7.14 2.30 3–10
8 Gain in quality of life 6.73 3.12 0–10
9 Waiting time 6.59 2.31 0–10
10 Gain in life expectancy 6.48 2.97 0–10
11 Number of children of
potential recipient
6.24 3.11 0–10
12 Other medical
conditions
5.67 2.83 0–10
13 Age 60 years+ 5.54 1.90 3–10
Factors rated from 0 (not at all important) to 10 (most important).
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next five interviews (AG and JB). There was substantial
coder agreement, and AG coded the remaining 26 inter-
views. The coding was completed in MSWord, then
entered into NVivo10 software. Reiteration of earlier
responses in later interviews indicated data saturation
had been achieved.
RESULTS
Participant characteristics
Table 2 shows participant characteristics. Participants
were recruited through 11 UK transplant centres. The
sample consisted of 10 deceased-donor (DD) kidney
transplant recipients, 10 LD kidney transplant recipients,
4 participants whose transplant failed postrecruitment to
ATTOM (Tx failed) and 12 participants wait-listed for a
kidney transplant (WL). Four LD recipients received a
transplant from a relative (1 parent donor, 3
adult-offspring donors), while 5 received an unrelated
transplant through the national paired LD exchange
scheme. The donors included in the scheme were rela-
tives (n=1), spouses (n=3) or friends (n=1). One LD
recipient received a transplant from a non-directed
(altruistic) living donor. Two LD recipients were never
wait-listed for a DD transplant. Wait-listed participants
were waiting for an average of 41 months. More DD
Table 2 Summary of demographic characteristics, time spent on dialysis and on waiting list for the four participant groups
DD (N=10) LD (N=10) WL (N=12) Tx failed (N=4)
Variable M (SD) M (SD) M (SD) M (SD)
Age (years) 52 (14.44) 53 (9.32) 53 (10.65) 53 (12.82)
Time on waiting list (months) 37 (34.48) – (–) 41 (26.99) 13 (11.59)
Time on dialysis (months) 28 (24.59) 28 (31.67) 39 (31.53) 15 (0.82)
Variable N (%) N (%) N (%) N (%)
Sex (female) 5 (50%) 5 (50%) 5 (41.6%) 1 (25%)
Diabetes (yes) 3 (30%) 1 (10%) 1 (8.3%) 1 (25%)
Previous transplant failure (yes) 2 (20%) 4 (40%) 6 (50%) 1 (25%)
Treatment modality (pretransplant)
Predialysis 3 (30%) 3 (30%) 2 (16.7%) –
Peritoneal dialysis (PD) 1 (10%) 1 (10%) 2 (16.7%) –
Haemodialysis (HD) 6 (60%) 6 (60%) 8 (66.6%) 4 (100%)
Marital status
Single 2 (20%) 2 (20%) 3 (25%) 1 (25%)
Living with partner 1 (10%) – – –
Married 5 (50%) 7 (70%) 7 (58.4%) 1 (25%)
Divorced/separated 1 (10%) 1 (10%) 1 (8.3%) 2 (50%)
Widowed 1 (10%) – 1 (8.3%) –
Education
No qualifications 2 (20%) 1 (10%) – 1 (25%)
Basic (O level/A level/NVQ 1–3) 4 (40%) 6 (60%) 9 (75.0%) 1 (25%)
Higher (degree/higher degree/NVQ 4–5) 4 (40%) 3 (30%) 3 (25.0%) 2 (50%)
Ethnicity
White 7 (70%) 10 (100%) 8 (66.7%) 4 (100%)
Black – – 3 (25%) –
Chinese 1 (10%) – –
Asian 1 (10%) – 1 (8.3%) –
Mixed 1 (10%) – – –
Transplant centre
Belfast 1 (10%) 2 (20%) – –
Birmingham 1 (10%) – 2 (16.7%) 1 (25%)
Bristol 2 (20%) – 1 (8.3%) –
Cambridge 1 (10%) 1 (10%) – –
Cardiff 1 (10%) – 1 (8.3%) 1 (25%)
Edinburgh 1 (10%) 4 (40%) 2 (16.7%) –
Guys – – – 2 (50%)
London West 1 (10%) 1 (10%) 3 (25%) –
Newcastle – – 1 (8.3%) –
Plymouth 2 (20%) – – –
St. Georges – 2 (20%) 2 (16.7%) –
DD, deceased-donor-kidney-transplant group; LD, living-donor-kidney-transplant group; Tx failed, patients whose transplant failed; WL,
patients wait-listed for a deceased-donor-kidney-transplant.
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Table 3 Themes and illustrative quotations
Theme Subtheme Illustrative quotations
Certainty of
knowledge of the
allocation system
Perceived
certainty
▸ “Well I know that erm, the individual recipient has to match the donor with a blood
type and antibody type and erm, I think there are 6 different numbers you’ve got to
match with, or as near as a match with, before you can actually match up” (Man, WL
pre-dialysis).
▸ “It goes by tissue matching. Basically like the lottery. I think you get, there’s six
things they got to match and the closest match, that’s how they allocate the kidneys
they give it to the closest match” (Man, DD transplant).
▸ “A lot of it goes on age and um compatibility so I believe the blood group is one of
the first things” (Woman, (non-related) LD transplant).
▸ “I understand it’s prioritises people who have been on the list for longer, waiting
longer” (Man, WL CAPD).
▸ “I know they like to have as good an age match between donors and recipients as
possible” (Woman, (non-related) LD transplant).
▸ “As far as I know obviously it’s all computerised and it’s the best match who gets
them” (Woman, (non-related) LD transplant).
▸ “Well as I understand it um at (NHS) Blood and Transplant have a national allocation
system. They, that essentially works on a combination of blood type and things like
that and tissue typing, the kidneys are allocated on best match but that is flexed by
need and time on the waiting list. So you have a combination of best match,
overridden by someone who may have an urgent need or someone who spent an
extremely long time on the waiting list” (Man, DD transplant).
Knowledge
uncertainty
▸ “I don’t know, I don’t know what the system is” (Man, HD following failed DD
transplant).
▸ “I don’t, I haven’t got a clue how they’re allocated” (Man, (related) LD transplant).
▸ “I pretty much confess to a certain amount of ignorance because when I had my first
one there was a points system and I was a young father, 40, and as I said to you
before they wanted to try and transplant a few people early on, so I did, they claim,
they say there’s not a points system any more but I think probably some people’s
need is greater than others. And so I’m a little bit in the dark” (Man, WL HD).
▸ “I don’t know masses about it I’ve gotta be honest but my, my guess is they, erm
they would look at how match(ed) the kidney is, they would look at how long people
have been on the waiting list, they would look at probably age, I would say those are
probably the key things, how long you’ve been on there, what kind of a match it’s
gonna be for you and what age, say how much kind of benefit you’re gonna get from
it” (Man, (related) LD transplant).
▸ “Well you get slightly different stories from slightly different people it has to be said.
Um you know allegedly there’s not a top of the list; right I mean allegedly it kind of
works by a points system and all this kind of thing. But, um if you, I mean I only
know in my personal circumstance I’ve been told that you know, I am now near the
top of the list so there obviously is a priority sort of system” (Woman, WL
predialysis).
Evaluation of the
system
Perceived
fairness
▸ “I think the guidelines are very fair! I mean it’s unfortunate if you’ve got a, a different
metabolism as much as you’re a different blood group or your whatever it is, the
kidney doesn’t match” (Man, DD transplant).
▸ “I think it’s fair, you know I don’t think anybody should be playing God and deciding
ok this person is more needy therefore you get it. Sometimes it’s unfair when you
see like, somebody who is young, with family and stuff not getting one, but then I
wouldn’t want to be the person on that board deciding between that person and
somebody else. The way they do allocate kidneys is much more neutral” (Woman,
DD transplant).
▸ “Not knowing enough about how it’s allocated, I would have to assume it’s been set
up in a good way that it is fairly fair… I would just have to assume that it’s been set
up in a good way so” (Man, (non-related) LD transplant).
▸ “(It’s) probably not a fair system but I mean there’s also things like I mean I know it
shouldn’t matter but I’m not sure geographically um, I mean allegedly it’s all one
system and you would get a kidney you know from the south of England or whatever
but… um technically everybody should have an equal chance, I’m not entirely sure
Continued
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Table 3 Continued
Theme Subtheme Illustrative quotations
that’s how it works. But I don’t think that’s necessarily wrong” (Woman, WL
predialysis).
Trust ▸ “Well not knowing enough about how it’s allocated, I would have to assume it’s been
set up in a good way that it is fairly fair but um, so yes I do not know all the ins and
outs of the allocation system so I um, I would just have to assume that it’s been set
up in a good way” (Man, (non-related) LD transplant).
▸ “I suppose the consultant sees the patient and we should all trust the consultants
that they’re gonna be… if there’s fraudulent or back-handed things going on then if
we can see everything’s kosher and they’re making the right decisions for the right
reasons” (Woman, predialysis DD transplant).
▸ “I hope that it is (a fair system). I don’t have any knowledge of it but I hope that there
is and they’re not cheating me out of a kidney!” (Man, WL CAPD).
Patient
suggestions
Medical priority ▸ “I suppose priority would be um people who really needed it if they were ill. But then
I think you have to look at, there’s so many points to look at isn’t there. You’ve gotta
be healthy enough to receive it. It’s no good going through a major operation if you
… you’ve got to be fit enough to have it)” (Woman, HD following failed DD
transplant).
▸ “But I think that because of the time and the money it costs I think the money should
be best spent and the person most suitable to that kidney… the one that’s most
likely to be successful” (Man, (related) LD transplant).
▸ “And if it’s so much to do with the individual then I guess it has to be um a match, a
match basis like they’re on cos they, ultimately whether it’s going to work or not,
medically, whether it’s going to work or not, they don’t just have to take the gamble
medically on that and the best match has to be the thing that takes priority over
everything. Always cos then the long-term prognosis is what they care about”
(Woman, (non-related) LD transplant).
▸ “If you give a kidney to someone who doesn’t best match it, it might only last them
an hour or a day and then it’s wasted. Someone who’s a 100% match it could go
forever and forever, you know it could last them forever” (Woman WL HD).
▸ “Well it shouldn’t really matter because as I say it’s only if it’s a proper match. I mean
obviously if you’ve got a guy with a couple of kids and a guy at 60, then it’s the
same match, a proper match then obviously the younger person should get it. But
there’s no point. They match the kidneys at present to the age group if they possibly
can. I mean there’s little point in putting a 60 year old kidney into a 20 year old is
there? It’s got to be a match” (Man, DD transplant).
▸ “I suppose like people with the worst kidney function obviously need a kidney first”
(Man, DD transplant).
▸ “Well it’s important to give it to the person who needs it most I think” (Man, DD
transplant).
Increasing life
expectancy
▸ “I mean if you had an 85-year-old who’s been on the waiting list for goodness knows
how long, and you’ve got a 30-year old and a kidney comes up and it’s suitable for
both of them, I would have thought that common sense would say the 30-year-old
would get it” (Man, pre-dialysis, LD transplant).
▸ “You have to figure out how old are people who receive a kidney, they’re more likely
to have other health, health side effects than someone who’s younger… and also if
you’re older you know, and you’re like a widow or something then your social life is
gonna be less than someone who’s younger you know, who’s just got married and
has got kids and stuff like that” (Man, DD transplant).
▸ “I’ve lived my life. I’m 66 now and if there was a young person lying in bed beside
me and two of us could, I would say give it to that, give it to that young life. Yes I
would. But that’s my personal thought. So I’ve lived my life, this guy’s just starting
out, you know” (Woman, DD transplant).
▸ “If you were something like 80 you wouldn’t expect to live more than another ten
years or something like that, where if you get it when you’re 20, you could live
another 60 years or something like that. So um, so yes I think it’s quite important
obviously if it can give a longer, if you’re saying if it can give a longer lifespan then
it’s, um, that should be weighted into it” (Man, (non-related) LD transplant).
Continued
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recipients reported having fewer educational qualifica-
tions, were from a wider range of transplant centres and
had greater ethnic diversity than the other groups.
Main qualitative analyses
Three main themes emerged: certainty of knowledge;
evaluation of the system and patient suggestions (see
online supplementary appendix 2). See table 3 for
themes and subthemes.
Certainty of knowledge
Few participants reported detailed knowledge of the
system, while many were unsure of how kidneys are allo-
cated. Despite this, the majority correctly identified
medical factors such as blood group and HLA typing as
important, although all participants referred to HLA
matching as ‘tissue matching’. Several participants
correctly believed that recipient age was a factor, with
younger people more likely to be prioritised. One DD
recipient felt that there was an upper age limit for
receiving a transplant, but was unsure of accuracy: “I
think if you’re over, I don’t know, 60 or 70 you may be
less likely to get one… I don’t know whether I’m right
in that or not, but that’s my perception” (Woman, non-
related LD transplant).
Some transplant recipients were correctly aware that
waiting time is a factor, but very few were aware of how
multiple factors combine to determine organ allocation.
Some felt more knowledgeable about how factors inter-
relate than others, but were still uncertain that their
information was accurate. Participants whose transplants
failed were knowledgeable about HLA typing and its
importance in determining allocation. One participant
in particular was very knowledgeable of the system,
Table 3 Continued
Theme Subtheme Illustrative quotations
▸ “Well if that person was the main parent and they got two kids whatever, and if that
person doesn’t survive because they didn’t receive a kidney, and then the kids have
to go into care then you know there should be some priority over that [when] you’ve
got two dependants, you know, little ones to look after (rather) than someone who
hasn’t got anyone (to look after)” (Man, DD transplant).
Priority based on
recipient factors
▸ “I had a two year old child when I first had a transplant so I mean, you could argue
that there was a child dependent on me but that, I‘m no more special than anyone
else” (Woman, WL predialysis).
▸ “That’s their fault (they had children)! If you choose to have children, you don’t think
well if I have more children I’m more likely to get a kidney transplant. No that’s not
fair” (Woman, pre-dialysis DD transplant).
▸ “I think everyone should be treated equally whatever age” (Woman, DD transplant).
▸ “I may have been more predisposed to say you know that younger ones should have
priority, but since my father died I would have argued very strongly that he was
entitled to just as many, you know as equal an opportunity as anyone else” (Woman,
DD transplant).
▸ “I mean people might say oh yes you know she’s a mum and she’s got two young
children, she should have priority whereas that’s chap’s 70 and shouldn’t… I don’t
think that’s a fair way to do it because who’s to say, who’s to judge that that person
is more deserving of it, or would benefit from it more? I think that has to be a medical
decision” (Woman, WL pre-dialysis).
▸ “Why should someone of a younger age be more entitled than someone of an older
age?” (Man, (related) LD transplant).
▸ “If a young person has a chance of a decent life but then a middle aged man wants
a chance of a decent life, he’s got a family. He may be older, he’s got a family and
you know you can get to my stage of life and still have a family, still have a wife and
you still want your shot! I think everybody should have an equal shot” (Man, WL HD).
Deservingness ▸ “You think about it people go on the transplant list, on the donor list then they should
be worth more, get more marks than people who are not on it. So if you’ve been on
the transplant list 20 years, and on the donor list for 20 years and you’re an equal
match as somebody that’s not on the, on the donor list, you should give them
priority” (Man, pre-dialysis DD transplant).
▸ “If people are grossly overweight, diabetic you know I mean a lot of, I mean you
could argue the case all these people are sort of self-inflicted like you know?” (Man,
LD transplant).
▸ “I think people uh, who are extremely ill and who deserve it, which for me would be
young people, people with families, that kind of thing” (Man, WL pre-dialysis).
CAPD, continuous ambulatory peritoneal dialysis; DD, deceased-donor-kidney-transplant group; HD, haemodialysis; LD, living-donor-kidney-
transplant group; Tx failed, patients whose transplant failed; WL, patients wait-listed for a deceased-donor-kidney-transplant.
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although he was uncertain about his accuracy: “I believe
there’s a points system and how that works specifically I
don’t really know. But I believe that the kidneys would
be allocated on what would be the best match, medical
match. I believe that children will probably take priority
over older people. Whether that’s true or not I don’t
know but that’s what I understand. I believe if there is
more than; if there’s a really good match but more than
uh, you know one person that it would be a match to,
then that’s when I believe the time you’ve been waiting
on the waiting list would then come in. So if there’s a
donor kidney that would match four people it would go
to the person who’s been on the list the longest” (Man,
on HD following failed DD transplant).
Some participants correctly believed that it is a
national allocation system, with a small minority incor-
rectly believing that wait-listed participants move up the
list in a sequential order. Three LD recipients were
unsure of the system, but overall, LD recipients and WL
participants were more familiar with the points system
than the DD recipients who were beneficiaries of this
system. WL participants were more likely to report
seeking information, and participants whose transplants
failed recalled being given information from surgeons
and transplant coordinators, while those wait-listed for a
transplant and LD recipients mentioned medical staff,
seminars and information evenings more often. DD reci-
pients reported receiving written information and
researching the scheme on the internet. Most reported
being satisfied with the information they received,
although a fifth of participants expressed a wish for
further information.
Evaluation of the system
When asked to describe the current system, 22 partici-
pants made evaluative judgements about its fairness.
Patients regarded equity and fairness as synonymous. On
the basis of their current knowledge of the system, 17
participants felt that the current system was fair,
although 5 felt that it was not. They believed that some
people were prioritised over others based on age and/or
ethnicity, but did not necessarily believe that the system
required change.
Several participants felt that they could trust their
doctors, but also felt that if more information was avail-
able they could trust them more. One DD recipient
believed very strongly that non-related living donation
contradicts the information given about matching.
Although details of the scheme are available online, this
participant felt there was a lack of transparency: “…
there’s also this sneaking suspicion that someone some-
where gets to make a moral judgement on when the
kidneys are handed out and to whom … I’d be much
happier if I knew that it was absolutely numerical and
somebody wasn’t making a judgement call on it at some
point … you’ve got no way of checking that because
none of this is in the open” (Man, DD transplant).
Patient suggestions
When participants were asked how kidneys should be
allocated, various factors were discussed, including
matching, age, perceived medical need, dependants,
waiting time and lifestyle factors. These factors were
categorised under the themes medical priority, increas-
ing life expectancy, priority based on recipient factors
and deservingness.
Medical priority
When asked what factors should be important in decid-
ing who receives a kidney transplant, the main factor
recognised spontaneously to be of primary importance
by 20 participants was matching (HLA and/or blood),
within the context of medical priority. Participants felt
so strongly about the importance of matching that many
felt non-medical factors such as waiting time were irrele-
vant: “Your time on the transplant list is governed by if
you’re a perfect tissue match. That’s it. You know you’ve
got,… if it’s not a perfect tissue match it’s not going to
take and if it’s not going to take it’s not worth having…
you’ve just got to wait. You can’t decide well I’ve waited
5 years I should have the next one” (Man, WL, on HD).
Non-medical factors were considered secondary to
having a successful, well-matched kidney: “I think what
you’re looking for is two things, you want the kidney to
last and be as close a match as possible” (Woman, DD
transplant). Nine participants also felt that people with
the most perceived medical need or who are the most ill
should be given priority: “Some people may be very, very
ill and need the transplant… that should be taken into
account” (Man, (related) LD transplant).
Increasing life expectancy
Participants held opposing beliefs about the importance
of recipient factors in prioritising kidney allocation.
These were often based on beliefs surrounding increas-
ing life expectancy. Many participants felt that young
people have yet to live their lives fully, and prioritising
them allows them this chance: “I probably think that if
you had to choose between a 20-year-old or a
90-year-old, I would probably give it to the younger one
because they got their life to live whereas the 90-year-old
has lived their life” (Man, DD transplant). At the same
time, being older was considered to bring more risk of
having other conditions that may complicate the success
of a transplant and limit any gains in life expectancy.
Priority based on recipient factors
Although many participants felt that medical priority
through matching was important, eight others felt it was
unfair for anyone to receive priority based on recipient
factors, including time on the waiting list, ethnicity, reli-
gion, younger age or having children: “I don’t see why
one person should have advantage over another”
(Woman, (non-related) LD transplant). These partici-
pants felt that those who are younger should not receive
priority, there should be an equal chance for all to
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receive a transplant: “everybody should get an equal
chance, just because you’re older, you still want to live,
you still want to see your grandkids or your great-
grandchild” (Woman, WL, on HD). Participants also
noted that it would be unfair if those unable or unwill-
ing to have children because of their renal condition
were less likely to receive a transplant.
Deservingness
The issue of deservingness was also considered when dis-
cussing what factors should be used; two WL participants
felt that patients who abuse their body via drugs or
alcohol should be given less priority, while one DD trans-
plant recipient believed that those willing to donate
organs or who are already on the Organ Donor Register
should be given priority if they require a transplant:
“People who are willing to donate should be given a bit
more priority than people who haven’t, as an incentive
(to donate)” (Man, DD transplant).
At the end of each interview, participants were asked
to rate the importance of 13 factors in deciding priority
for who should be allocated a kidney (table 1). Factors
relating to medical priority were rated the highest; tissue
matching was regarded as the most important, with the
likelihood of dying soon without a transplant being con-
sidered the second most important factor. Being
younger than 18 years of age was considered the third
most important. No variable was considered unimport-
ant, although having other medical conditions, being
older than 60 years, and having children or dependants
were rated as least important for kidney transplant
allocation.
DISCUSSION
Although participants in our study were knowledgeable
about some aspects of the current UK allocation system,
they were not certain their knowledge was accurate.
Participants may have been reluctant to place confi-
dence in their knowledge, assuming that the interviewer
had greater knowledge than them, though the woman
interviewer made no claim to such knowledge.
Interestingly, some groups such as those currently wait-
listed were more knowledgeable than others. These par-
ticipants had been wait-listed for 41 months on average
and were more likely to report seeking information. In
contrast, DD recipients may not have retained informa-
tion about a system in which they are no longer involved.
Although LD recipients received donations outside of
the allocation scheme, they were more likely to be aware
of the points system than DD recipients. Most were listed
for a DD transplant before receiving a LD transplant
and fewer LD recipients and WL patients reported
having no qualifications. The DD recipients were from a
wider range of transplant centres and had greater ethnic
diversity. It may be that the differences in knowledge
reflect these differences in sociodemographic factors,
rather than treatment group, but further work is
warranted to assess if this is the case. However, the find-
ings suggest that few participants are confident in their
knowledge of the system.
Few participants were aware of the structure of the
kidney allocation system, believing that patients receive a
kidney in a sequential order. In the absence of full
knowledge of the allocation system, participants may
attempt to make sense of the system by oversimplifying it
through incorrectly anchoring it to their social represen-
tation of what constitutes a waiting list.17 Reference to
being on a ‘waiting list’ may contribute to confusion
about the way the system is structured. Perhaps replacing
the term ‘waiting list’ with ‘waiting pool’ may therefore
facilitate more appropriate understanding of how the
allocation system works. Although the technical details
of the allocation scheme are available online, few partici-
pants had accessed this information. Information is
more effective if tailored to patients,18 and there is a risk
that highly technical information may not be helpful to
most patients. Health literacy is low in patients with
kidney disease19 and patients’ knowledge of their
disease may be limited,20 so how best to make informa-
tion available to patients may need to be reconsidered.
In line with previous research from the USA,21 the
majority of participants trusted that the allocation system
was fair, while a minority of participants perceived a lack
of transparency in how kidneys are allocated. Feeling
ill-informed may lead to dissatisfaction with subsequent
treatment. Despite this, the majority of participants said
they were content with the information they received, so
the provision of further medical detail may not be
required. Instead, an explanation of how the factors
inter-relate in the allocation process may be more
useful. Managing expectations of transplantation affects
how patients cope post-transplant,22 23 so it is important
that more information be provided about the weight
given to matching, and the quality of the kidneys, to
help manage patient expectations of transplant survival.
Longer waiting times have been shown previously to be
an important factor to UK patients,8 10 but this was not
found here. Participants believed that medical priority
was the most important; where there is a good match it
should be used regardless of waiting time, with a prefer-
ence for waiting longer for a better-matched kidney. In a
US study, Louis et al16 suggested that when patients have
seen how detrimental a poor match can be, they may
place more value on matching. In the current study,
almost half of participants had at least one previous
transplant, and all participants whose transplant failed
considered matching to be of utmost importance. This
may help explain the lack of weight given to waiting
time by these participants.
Better matching and younger age were considered the
most important factors in determining kidney allocation,
which have been identified previously as important to
Australian and UK patients.7 8 Participants were more
likely to prioritise children based on the expectation of
increasing life expectancy, and being older was
Gibbons A, et al. BMJ Open 2017;7:e013896. doi:10.1136/bmjopen-2016-013896 9
Open Access
considered to bring more risk of having other conditions
that may limit life expectancy, or even preclude trans-
plantation. In contrast, a substantial minority of partici-
pants felt that no personal characteristics, including age,
should be used to prioritise patients. The reason the
current scheme prioritises younger patients for better-
matched kidneys is in part to ensure that future trans-
plantation is more easily achieved through avoiding
development of antibodies to HLA. The provision of
patient-friendly information would explain the reasoning
behind prioritising particular groups, which may lead to
greater acceptance and understanding of the factors
used and of the system overall.
Participants felt that those who have the most medical
need for a transplant should be prioritised. There was
also acknowledgment that kidneys should be allocated to
those who have the best chance of surviving and main-
taining a functioning transplant.7 Allocating kidneys
according to medical criteria was considered the best
way to allocate organs, which has been found previously
in liver transplantation where medical need is assumed
to be an objective way to allocate organs, despite the fact
that it may require moral judgement.24 Patients are
aware of some of the issues surrounding allocation, but
without complete information, patients cannot make
well-informed judgements about policies. Previous
scheme development has included patient representa-
tion, but providing further information to patients about
the system may help them feel more confident of their
knowledge and opinions as to how the system might be
improved.
Although medical need and the use of medical cri-
teria were seen to be important, non-medical and recipi-
ent factors were also discussed. For example, having
children or dependants was one of the lowest-rated
factors, but was raised repeatedly in the interviews. In
line with our findings, there is inconsistency in the lit-
erature in preferences for this factor, with some UK
studies indicating that patients wish to give greater prior-
ity to those with dependants,9 while an Australian study
reported more mixed views.7 Those who do not believe
that priority should be based on recipient factors were
less likely to consider having dependants as worthy of
prioritising patients for kidney allocation, so there is no
consensus as to its perceived importance.
A small number of participants felt that patients
whose kidneys were damaged by behaviours such as
substance misuse were less deserving of a kidney trans-
plant. Other research has shown that participants con-
sider moral deservingness when discussing kidney
transplantation.7 Previous research from the UK and the
Netherlands has shown that kidney recipients reported
feeling gratitude and a sense of duty to their donors to
take care of their kidney,22 23 so allocating transplants to
those considered at risk of not taking care of their
kidneys may explain why these factors were considered
important in the current study.
The factors rated by participants at the end of the
interview showed general agreement with the factors
discussed in the interviews. Ratings varied widely,
however. Participants found it difficult to distinguish
the perceived importance of the factors listed with
many showing ceiling effects. In contrast, participants
were able to show distinct preferences when asked
more general questions about how kidneys should be
allocated in the interviews. Although participants were
encouraged to elaborate on their ratings, few partici-
pants did so, although some of the factors had already
been discussed in the interviews. Despite this, the dif-
ferences in ratings and those factors discussed in inter-
views suggest that qualitative designs may be more
effective in eliciting greater insight into participants’
beliefs and preferences.
Strengths and weaknesses of the study
The interviews were conducted with participants
recruited to ATTOM, and as with all qualitative studies,
the results cannot be generalised to all renal patients or
other organ allocation schemes. No attempt was made
to achieve a representative sample, so any frequencies
given are not necessarily representative of the patient
group as a whole. Moreover, comparisons between
groups should be noted with caution, as the groups dif-
fered in demographic factors such as education level
and ethnicity. The interviews were conducted with
English-speaking participants from a subsample of trans-
plant centres in the UK. The results therefore may not
reflect fully the views of people of ethnic minority
origin. Patients deemed unsuitable for transplant listing
were not included in the present interview sample.
Despite this, collecting qualitative data allowed us to
delve further into patients’ understanding of the alloca-
tion system. This is one of only a handful of studies
examining patient beliefs about kidney allocation. Very
little research has examined patients’ views of kidney
allocation and this study is timely to inform forthcoming
guideline development and allocation scheme revision.
Assessing a large group of patients who have yet to be
listed would inform us of what patients know of the
system before, during and after listing for a kidney trans-
plant. This study does not provide a comprehensive
understanding of patient knowledge, but instead pro-
vides a snapshot of such knowledge (or lack of knowl-
edge) may relate to patient suggestions for the
allocation scheme.
A representative survey to quantify knowledge, as well
as issues regarding age priority, waiting time and the
importance of dependants, would help further to
describe and understand patient’s beliefs and priorities.
This study focused exclusively on renal patients; there
is a case for considering the views of potential kidney
donors and perhaps the wider population for their
level of engagement and knowledge of transplantation
issues.
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CONCLUSIONS
This study highlights that patients vary in their views and
their priorities for kidney allocation. Most participants
were uncertain of the accuracy of their knowledge. The
majority of participants were aware that a number of
factors are important, and most were content with their
level of knowledge, so tailoring information to allow
greater explanation of how factors in the allocation
system relate to one another may be important in
increasing patients’ perceived ability to make informed
decisions about the system. Although further work is
warranted to assess it, replacing the term ‘waiting list’
with ‘waiting pool’ may perhaps facilitate more appropri-
ate understanding of how a points-based allocation
system works. Policymakers should continue to consult
with patients, as it reveals patient knowledge and under-
standing, identifies information needs and provides
guidelines for what factors may be considered accept-
able to patients, which may help increase patients’ confi-
dence in being involved in treatment decision-making,
and ultimately increase patient satisfaction.
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